Kazuto Kitamura

Sensitivity and accuracy in recording his-purkinje activity by surface-averaged electrocardiography

A clinical evaluation of the surface-averaged ECG (SAE) to record His-Purkinje activity (HPA) was made on 70 patients who underwent His bundle electrograms (HBE). The recorded signals first judged as HPA in 43 patients by the noninvasive method alone were later verified in 37 patients by HBE; the accuracy of the HPA recordings (predictive value) was 86.0%. The HPA-V interval measured noninvasively had a high correlation with the HV interval by HBE (r = 0.89, p less than 0.01). The verified detection rate in all 70 patients was 52.9%: HPA was detected in 12 of 18 patients (66.7%) with sclerotic and hypertensive heart disease (Group I), five of 19 patients (26.3%) with rheumatic heart disease (Group II), 11 of 17 patients (64.7%) with congenital heart disease (Group III), and nine of 16 patients (56.2%) with miscellaneous conditions (Group IV). The detection rate was markedly lower in Group II than in other groups (Group II vs Group I or III, p less than 0.025). The PR segment was significantly longer in the patients in whom HPA was detected than in those in whom it was not detected (71.5 +/- 22.3 msec vs 43.9 +/- 19.5 msec, p less than 0.001). His-Purkinje activity (HPA) was detected in 32 of 52 recordings (61.5%) with sinus rhythm and seven of 20 recordings (35.0%) with atrial fibrillation, including two recordings in each of two cardioverted patients (p less than 0.05). We conclude that the surface-averaged ECG (SAE) has clinically acceptable sensitivity and accuracy except in patients with rheumatic heart disease, short PR segments or atrial fibrillations.

Double ventricular parasystole associated with complete atrioventricular block

14. Kaplan MH, Frengley JD: Autoimmunity to the heart in cardiac disease: Current concepts of relation of autoimmunity to rheumatic fever, postcardiotomy and post infarction syndromes and cardiomyopathies. Am J Cardiol 24:459, 1969. Spagnulo M, Taranta A: Rheumatic fever in siblings: Similarity of its clinical manifestations. N Engl J Med 278:183, 1968. Murphy GE: Nature of rheumatic heart disease with special reference to myocardial disease and heart failure. Medicine 39:289, 1968. Falk JA, Fleischman JL, Zabriskie JB, Falk RE: A study of HL-A antigen phenotype in rheumatic fever and rheumatic heart disease patients. Tissue Antigens 3:173, 1973. Caughey DE, Douglas R, Wilson W, Hassall IB: HL-A antigens in Europeans and Maoris with rheumatic fever and rheumatic heart disease. J Rheumatol 2:319, 1975. Joysey VC, Roger JH, Ashworth F, Bullman W, Hazleman BL. Lachmann M. Watson PG: Parallel studies of HLA antigens in patients with rheumatic heart disease and scleritis: Comparisons with 3 control populations. J Rheumatol (suppl 3) 4:84, 1977. Murrav GC. Monteil MM. Persellin RH: A studv of HLA antigens in adults with acute rheumatic fever. Arthritis Rheum 21:652, 1978. Leirisalo M, Koivuranta P, Laitinen 0: Rheumatic fever and its sequels in children-A follow-up study with HLA analysis. J Rheumatol 7x506, 1980. Naito S, Arakawa K, Kanaya H, Doi Y, Sasaki Y, Sakai T, Akaiwa H, Takeshita A, Saito S, Toyoda K: HLA and cardiovascular disease. Jpn Circ J 42:1196, 1978. Naito S: HLA and disease-heart valvular disease and aortitis syndrome. Jpn J Med 19:66, 1980. Matsunori A, Hirose K, Wakabayashi A, Kawai C, Nabeya N, Sakurami T, Tsuji K: HLA in hypertrophic cardiomyopathy and rheumatic heart disease. Jpn Circ J 43:445, 1979. Ward C, Gelsthorpe K, Doughty RW: A relation between HLA antigens and clinical features in patients with acquired valvular heart disease. Br Med J 1:1499, 1976. Swint RE, Haines RF, Tsai CT, Willis PW: HLA antigen phenotype in f i f ty patients with rheumatic valvular cardiac disease (abstr). Am J Cardiol 39:299, 1977. Braun WE, Ronan J, Schacter B, Gardin J, Isner J, Grecek D: HLA antigens in mitral valve prolapse. Transplant Proc 9:1869, 1977.